Abstract
Summary
Sevoflurane, also called fluoromethyl, is an ether inhalation anaesthetic agent used for the induction and maintenance of general anesthesia.
The global market for Inhalation Sevoflurane Anaesthetic Agent was estimated to be worth US$ 976 million in 2023 and is forecast to a readjusted size of US$ 1443.4 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030
The Inhalation Sevoflurane Anaesthetic Agent market is primarily driven by the demand for safe and effective inhalation anesthetic agents used during surgical procedures and medical interventions. Sevoflurane is a widely used inhalation anesthetic known for its rapid onset and recovery properties, making it suitable for both adults and pediatric patients. The increasing volume of surgical procedures, coupled with advancements in anesthesia technology and the focus on patient comfort, contributes to market growth. Moreover, the demonstrated benefits of sevoflurane in providing smooth induction and emergence from anesthesia, reducing side effects, and offering precise control over depth of anesthesia further propel adoption. However, challenges include optimizing dosing protocols, addressing potential adverse effects, and ensuring proper anesthetic management. Navigating patient-specific considerations, adhering to safety guidelines, and providing adequate training to anesthesiologists are ongoing concerns. The market's success relies on continuous research in anesthesia care, collaborations between pharmaceutical manufacturers and medical practitioners, and comprehensive education on the benefits and potential challenges of using sevoflurane as an inhalation anesthetic agent while addressing the evolving challenges associated with perioperative care and patient safety.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhalation Sevoflurane Anaesthetic Agent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Inhalation Sevoflurane Anaesthetic Agent by region & country, by Type, and by Application.
The Inhalation Sevoflurane Anaesthetic Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalation Sevoflurane Anaesthetic Agent.
Market Segmentation
By Company
AbbVie
Baxter
Maruishi Pharmaceutical
Jiangsu Hengrui
Lunan Pharmaceutical
Segment by Type:
Generic Drug
Brand Drug
Segment by Application
Chidren
Adult
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Inhalation Sevoflurane Anaesthetic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Inhalation Sevoflurane Anaesthetic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Inhalation Sevoflurane Anaesthetic Agent in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Inhalation Sevoflurane Anaesthetic Agent was estimated to be worth US$ 976 million in 2023 and is forecast to a readjusted size of US$ 1443.4 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030
The Inhalation Sevoflurane Anaesthetic Agent market is primarily driven by the demand for safe and effective inhalation anesthetic agents used during surgical procedures and medical interventions. Sevoflurane is a widely used inhalation anesthetic known for its rapid onset and recovery properties, making it suitable for both adults and pediatric patients. The increasing volume of surgical procedures, coupled with advancements in anesthesia technology and the focus on patient comfort, contributes to market growth. Moreover, the demonstrated benefits of sevoflurane in providing smooth induction and emergence from anesthesia, reducing side effects, and offering precise control over depth of anesthesia further propel adoption. However, challenges include optimizing dosing protocols, addressing potential adverse effects, and ensuring proper anesthetic management. Navigating patient-specific considerations, adhering to safety guidelines, and providing adequate training to anesthesiologists are ongoing concerns. The market's success relies on continuous research in anesthesia care, collaborations between pharmaceutical manufacturers and medical practitioners, and comprehensive education on the benefits and potential challenges of using sevoflurane as an inhalation anesthetic agent while addressing the evolving challenges associated with perioperative care and patient safety.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhalation Sevoflurane Anaesthetic Agent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Inhalation Sevoflurane Anaesthetic Agent by region & country, by Type, and by Application.
The Inhalation Sevoflurane Anaesthetic Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalation Sevoflurane Anaesthetic Agent.
Market Segmentation
By Company
AbbVie
Baxter
Maruishi Pharmaceutical
Jiangsu Hengrui
Lunan Pharmaceutical
Segment by Type:
Generic Drug
Brand Drug
Segment by Application
Chidren
Adult
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Inhalation Sevoflurane Anaesthetic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Inhalation Sevoflurane Anaesthetic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Inhalation Sevoflurane Anaesthetic Agent in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Inhalation Sevoflurane Anaesthetic Agent Product Introduction
1.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Forecast
1.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value (2019-2030)
1.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume (2019-2030)
1.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Price (2019-2030)
1.3 Inhalation Sevoflurane Anaesthetic Agent Market Trends & Drivers
1.3.1 Inhalation Sevoflurane Anaesthetic Agent Industry Trends
1.3.2 Inhalation Sevoflurane Anaesthetic Agent Market Drivers & Opportunity
1.3.3 Inhalation Sevoflurane Anaesthetic Agent Market Challenges
1.3.4 Inhalation Sevoflurane Anaesthetic Agent Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Inhalation Sevoflurane Anaesthetic Agent Players Revenue Ranking (2023)
2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Company (2019-2024)
2.3 Global Inhalation Sevoflurane Anaesthetic Agent Players Sales Volume Ranking (2023)
2.4 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Company Players (2019-2024)
2.5 Global Inhalation Sevoflurane Anaesthetic Agent Average Price by Company (2019-2024)
2.6 Key Manufacturers Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Inhalation Sevoflurane Anaesthetic Agent Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Inhalation Sevoflurane Anaesthetic Agent
2.9 Inhalation Sevoflurane Anaesthetic Agent Market Competitive Analysis
2.9.1 Inhalation Sevoflurane Anaesthetic Agent Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Inhalation Sevoflurane Anaesthetic Agent Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalation Sevoflurane Anaesthetic Agent as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Generic Drug
3.1.2 Brand Drug
3.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type
3.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value, by Type (2019-2030)
3.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value, by Type (%) (2019-2030)
3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Type
3.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume, by Type (2019-2030)
3.3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume, by Type (%) (2019-2030)
3.4 Global Inhalation Sevoflurane Anaesthetic Agent Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Chidren
4.1.2 Adult
4.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application
4.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value, by Application (2019-2030)
4.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value, by Application (%) (2019-2030)
4.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Application
4.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume, by Application (2019-2030)
4.3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume, by Application (%) (2019-2030)
4.4 Global Inhalation Sevoflurane Anaesthetic Agent Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Region
5.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Region (2019-2024)
5.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Region (2025-2030)
5.1.4 Global Inhalation Sevoflurane Anaesthetic Agent Sales Value by Region (%), (2019-2030)
5.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Region
5.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Region (2019-2024)
5.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Region (2025-2030)
5.2.4 Global Inhalation Sevoflurane Anaesthetic Agent Sales Volume by Region (%), (2019-2030)
5.3 Global Inhalation Sevoflurane Anaesthetic Agent Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
5.4.2 North America Inhalation Sevoflurane Anaesthetic Agent Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
5.5.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
5.6.2 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
5.7.2 South America Inhalation Sevoflurane Anaesthetic Agent Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
5.8.2 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Inhalation Sevoflurane Anaesthetic Agent Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Inhalation Sevoflurane Anaesthetic Agent Sales Value
6.2.1 Key Countries/Regions Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
6.2.2 Key Countries/Regions Inhalation Sevoflurane Anaesthetic Agent Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
6.3.2 United States Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
6.4.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
6.5.2 China Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (%), 2023 VS 2030
6.5.3 China Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
6.6.2 Japan Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
6.7.2 South Korea Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
6.8.2 Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Inhalation Sevoflurane Anaesthetic Agent Sales Value, 2019-2030
6.9.2 India Inhalation Sevoflurane Anaesthetic Agent Sales Value by Type (%), 2023 VS 2030
6.9.3 India Inhalation Sevoflurane Anaesthetic Agent Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Company Information
7.1.2 AbbVie Introduction and Business Overview
7.1.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2019-2024)
7.1.4 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Offerings
7.1.5 AbbVie Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Introduction and Business Overview
7.2.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Offerings
7.2.5 Baxter Recent Development
7.3 Maruishi Pharmaceutical
7.3.1 Maruishi Pharmaceutical Company Information
7.3.2 Maruishi Pharmaceutical Introduction and Business Overview
7.3.3 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Offerings
7.3.5 Maruishi Pharmaceutical Recent Development
7.4 Jiangsu Hengrui
7.4.1 Jiangsu Hengrui Company Information
7.4.2 Jiangsu Hengrui Introduction and Business Overview
7.4.3 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Offerings
7.4.5 Jiangsu Hengrui Recent Development
7.5 Lunan Pharmaceutical
7.5.1 Lunan Pharmaceutical Company Information
7.5.2 Lunan Pharmaceutical Introduction and Business Overview
7.5.3 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Offerings
7.5.5 Lunan Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Inhalation Sevoflurane Anaesthetic Agent Industrial Chain
8.2 Inhalation Sevoflurane Anaesthetic Agent Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Inhalation Sevoflurane Anaesthetic Agent Sales Model
8.5.2 Sales Channel
8.5.3 Inhalation Sevoflurane Anaesthetic Agent Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer